SK

Sunita Karanwal

Director Director DIN 01267182
DIN 01267182 First appointment Jun 1987 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 1987
Shareholding value •••• Premium profile

About Sunita Karanwal

Data last updated:

Sunita Karanwal was a Director at R K Medicines Private Ltd (1987–2020) and Director at Remed Healthcare Private Limited (1998–2022). The companies operate in Healthcare and Pharma.

DIN 01267182
Primary Designation Director
Industry Healthcare
First Appointment 20 Jun 1987

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
R K Medicines Private Ltd U74899DL1987PTC028244
Director20 Jun 19871987₹167 Cr (FY 2025)Active
Remed Healthcare Private Limited U51397DL1998PTC097203
Director26 Nov 19981998₹89.3 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
R K Medicines Private Ltd
Remed Healthcare Private Limited
Premium access

Shareholding and investment profile for Sunita Karanwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Karanwal

Sunita Karanwal was first appointed on 20 Jun 1987 as Director at R K Medicines Private Ltd. The most recent appointment on record is 26 Nov 1998 at Remed Healthcare Private Limited.

Sunita Karanwal held 2 earlier board appointments: R K Medicines Private Ltd (Director, 20 Jun 1987 to 05 Mar 2020); Remed Healthcare Private Limited (Director, 26 Nov 1998 to 21 Apr 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available